EUVIMEDEUVIMED entdecken
Crossref

Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal

Fiammetta Cosci, Virginie-Anne Chouinard, Guy Chouinard

Psychotherapy and Psychosomatics · 2024

DOI: 10.1159/000540031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychotherapy and Psychosomatics, 2024. Verfasst von Fiammetta Cosci und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Sciences, University of Florence, Florence, Italy. Hauptthemen laut MEDLINE: Substance Withdrawal Syndrome, Selective Serotonin Reuptake Inhibitors, Diagnostic and Statistical Manual of Mental Disorders, Serotonin and Noradrenaline Reuptake Inhibitors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) may cause withdrawal at dose decrease, discontinuation, or switch. Current diagnostic methods (e.g., DSM) do not take such phenomenon into account. Using a new nosographic classification of withdrawal syndromes due to SSRI/SNRI decrease or discontinuation [by Psychother Psychosom. 2015;84(2):63–71], we explored whether DSM is adequate to identify DSM disorders when withdrawal occurs.

Methods

Seventy-five self-referred patients with a diagnosis of withdrawal syndrome due to discontinuation of SSRI/SNRI, diagnosed via the Diagnostic Clinical Interview for Drug Withdrawal 1 – New Symptoms of Selective Serotonin Reuptake Inhibitors or Serotonin-Norepinephrine Reuptake Inhibitors (DID-W1), and at least one DSM-5 diagnosis were analyzed.

Results

In 58 cases (77.3%), the DSM-5 diagnosis of current mental disorder was not confirmed when the DID-W1 diagnosis of current withdrawal syndrome was established. In 13 cases (17.3%), the DSM-5 diagnosis of past mental disorder was not confirmed when criteria for DID-W1 diagnosis of lifetime withdrawal syndrome were met. In 3 patients (4%), the DSM-5 diagnoses of current and past mental disorders were not confirmed when the DID-W1 diagnoses of current and lifetime withdrawal syndromes were taken into account. The DSM-5 diagnoses most frequently mis-formulated were current panic disorder (50.7%, n = 38) and past major depressive episode (18.7%, n = 14).

Conclusion

DSM needs to be complemented by clinimetric tools, such as the DID-W1, to detect withdrawal syndromes induced by SSRI/SNRI discontinuation, decrease, or switch, following long-term use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Withdrawal SyndromeSelective Serotonin Reuptake InhibitorsDiagnostic and Statistical Manual of Mental DisordersSerotonin and Noradrenaline Reuptake InhibitorsMental DisordersHumansFemaleMaleMiddle AgedAdultInterview, Psychological

Stichwörter der Autor:innen

DSMDiagnosisSelective serotonin reuptake inhibitorSerotonin-norepinephrine reuptake inhibitorWithdrawal

Substanzen

Selective Serotonin Reuptake InhibitorsSerotonin and Noradrenaline Reuptake Inhibitors

Autor:innen und Institutionen

  • Department of Health Sciences, University of Florence, Florence, Italy.
  • International Lab of Clinical Measurements, University of Florence, Florence, Italy.
  • Department of Psychiatry and Neuropsychology, Maastricht University, Maastricht, The Netherlands.
  • Psychotic Disorders Division, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, USA.
  • University Mental Health Institute of Montreal, University of Montreal, Montreal, Québec, Canada.
  • Clinical Pharmacology and Toxicology Program, Royal College of Physicians and Surgeons, McGill University, Montreal, Québec, Canada.

Zitieren

APA

Cosci, F., Chouinard, V. A., & Chouinard, G. (2024). Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000540031

Vancouver

Cosci F, Chouinard VA, Chouinard G. Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal. Psychotherapy and Psychosomatics. 2024. doi:10.1159/000540031

BibTeX
@article{Cosci2024,
  author = {Cosci, Fiammetta and Chouinard, Virginie-Anne and Chouinard, Guy},
  title = {Selective Serotonin Reuptake Inhibitor and Serotonin-Noradrenaline Reuptake Inhibitor Withdrawal Changes DSM Presentation of Mental Disorders: Results from the Diagnostic Clinical Interview for Drug Withdrawal},
  journal = {Psychotherapy and Psychosomatics},
  year = {2024},
  doi = {10.1159/000540031}
}
Kostenlos starten →